A data management platform for infectious disease processing containing data from different organ chips

By introducing concurrent current limiting processing and reserve monitoring mechanisms into the data management platform, the loss problem caused by untimely processing of organ chip data is solved, and the smooth reception and processing of data is achieved, ensuring the stability and efficiency of the platform.

CN118737492BActive Publication Date: 2024-11-05JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION (PUBLIC HEALTH RESEARCH INSTITUTE OF JIANGSU PROVINCE)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411209291.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-11-05
Estimated Expiration
2044-08-30

AI Technical Summary

Technical Problem

The prior art can easily lead to untimely processing of the platform and data loss when processing large amounts of organ chip data.

Method used

A data management platform for infectious disease processing including concurrent current limiting processing is designed. By receiving chip data in real time, evaluating concurrency status, transmitting if preset standards are met, otherwise the current limiting processing is carried out, and some data is cached to monitor the changes in reserves in real time. , adjust the current limiting strategy to ensure smooth data reception.

Benefits of technology

It effectively avoids data loss, ensures normal reception and processing of data, and optimizes the processing capabilities of the data management platform through the current limiting processing and reserve monitoring mechanism to prevent the occurrence of high concurrency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118737492B_ABST
    Figure CN118737492B_ABST
Patent Text Reader

Abstract

The present invention discloses an infectious disease processing data management platform including data of different organ chips. The present invention relates to the technical field of organ chips, and solves the problem that when a large amount of chip data is simultaneously input into the platform in the same period, it is easy to cause the platform to process in a timely manner, resulting in the loss of some chip data. The present invention performs current limiting processing on chip data generated by different organ chips, and preferentially assesses whether the chip data generated at different times need to be current limited, and then performs unified current limiting based on the assessment results and the generation amount at the corresponding time. Subsequently, the reserve change of different chips after the current limiting processing is analyzed, and the relevant ratio of the current limiting is adjusted again based on the specific reserve change value. Not only can the relevant current limiting be effectively performed on the data, so that the data to be received will not be congested, to ensure the normal reception of data, but also the reserves of different chips are reasonably digested synchronously.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of organ chips, and in particular to an infectious disease processing data management platform containing data of different organ chips. Background Art

[0002] Organ-on-a-chip is a miniaturized biochip technology that can simulate the functions and physiological environment of human organs;

[0003] It has many significant features and advantages. First, organ chips can highly simulate the cell composition, structure and function of human organs. For example, heart organ chips can simulate the contraction and electrical signal conduction of cardiomyocytes; liver organ chips can simulate the metabolism and detoxification functions of the liver.

[0004] Organ chips have important applications in many fields. In drug development, they can more accurately predict the efficacy and toxicity of drugs, reduce animal experiments, and speed up the drug development process. For example, kidney organ chips can be used to evaluate the damage of drugs to kidney cells and avoid unexpected renal toxicity in clinical trials.

[0005] In the process of related management of chip data generated by different chips, the chip data generated is generally received directly, and the received chip data is classified and managed. However, the original processing method does not take the platform load problem into consideration. If a large amount of chip data is input into the platform at the same time, it will easily cause the platform to fail to process in time, resulting in the loss of some chip data. Therefore, the original data management method needs to be improved. Summary of the invention

[0006] In view of the shortcomings of the prior art, the present invention provides an infectious disease processing data management platform that includes data from different organ chips, which solves the problem that when a large amount of chip data is simultaneously input into the platform within the same period of time, it is easy for the platform to fail to process in a timely manner, resulting in the loss of some chip data.

[0007] To achieve the above objectives, the present invention is implemented through the following technical solutions: an infectious disease processing data management platform containing different organ chip data, comprising:

[0008] The chip data receiving end receives the pathological data generated by different chips in real time;

[0009] The concurrent receiving and evaluating end identifies whether the pathological data of different chips received at the current moment will cause a high concurrent processing process. If so, the concurrent current limiting processing end is executed to perform current limiting processing. If not, the pathological data of different chips received at the current moment are transmitted to the management database. The specific method is as follows:

[0010] Confirm the preset standard quantity L that this management platform can accept, where L is the preset value;

[0011] The pathological data capacity generated by different chips at the current moment is calibrated as R i-k , where i represents different chips and k represents different moments. i-k Perform summation to determine the total capacity value Rz at the current moment;

[0012] If L≥Rz, the pathological data of different chips generated at the current moment are transmitted to the management database. If L<Rz, the concurrent current limiting processing end is executed to perform current limiting processing;

[0013] The concurrent current limiting processing end performs current limiting processing on the pathology capacity generated by different chips based on the different pathology data capacities sent by different chips at the current moment, and caches the limited part of the pathology data. The cached part of the pathology data is processed again at the next moment. The specific method is as follows:

[0014] The capacity of different pathological data sent by different chips at the current moment is calibrated as R i-k , several groups R i-k Perform ratio processing and determine the ratio sequence;

[0015] Divide the preset standard quantity L that this management platform can receive into several different standard processing values ​​CL according to the determined ratio sequence i , based on the determined standard treatment value CL i And the pathological data capacity R of the corresponding chip i-k , determine the cache volume HC generated by the corresponding chip at this moment i =R i-k -CL i , and the corresponding data capacity is the standard processing value CL i The relevant pathological data is transmitted to the management database;

[0016] When processing the subsequent moments, if the total capacity value Rz confirmed at the corresponding moment is L>Rz, data is randomly extracted from the cached data until L≥Rz, and the platform receives the extracted data and the pathological data capacity generated at this moment;

[0017] The reserve monitoring end monitors the cache reserves generated in the continuous processing process in real time, and generates cache reserve change curves for different chips. Based on the real-time generated cache reserve change curves, it is evaluated whether the original current limiting strategy needs to be adjusted, and an adjustment signal is generated and transmitted to the current limiting strategy adjustment end. The specific method is as follows:

[0018] Based on the different total cache amounts generated by different chips, cache amount reserve change curves of different chips are generated in real time, and the cache amount reserve change curves of multiple groups of different chips are located in the same two-dimensional coordinate system;

[0019] Based on several groups of cache volume change curves generated in real time, the average values ​​of several cache volumes at the same time are determined, and then based on the confirmed average values, the average change curve is determined;

[0020] Process several groups of real-time changing buffer reserve change curves and mean change curves: mark the buffer reserve change curve at the top of the mean change curve as the upper curve, mark the buffer reserve change curve at the bottom of the mean change curve as the lower curve, identify the vertical distance L1 between the upper curve and the mean change curve at the current moment, and then identify the vertical distance L2 between the lower curve and the mean change curve at the current moment;

[0021] If L1+L2≥Y1, where Y1 is a preset value, an adjustment signal is generated and transmitted to the current limiting strategy adjustment terminal;

[0022] If L1+L2<Y1, monitor;

[0023] The flow limiting strategy adjustment end, based on the generated adjustment signal, makes relevant adjustments to the ratio sequence confirmed at the current moment and the real-time buffer reserve change curve, and determines the adjustment sequence. Subsequently, the pathological data is limited according to the adjustment sequence. The specific method is as follows:

[0024] Based on the determined adjustment signal, determine the chip to which the upper curve or the lower curve belongs, and determine the related ratio B, where B=L2÷L1;

[0025] Determine the internal ratio corresponding to the chip to which the upper curve belongs from the confirmed ratio sequence, and mark it as the ratio to be increased Dz, and then determine the internal ratio corresponding to the chip to which the lower curve belongs, and mark it as the ratio to be decreased DJ;

[0026] Use DJ×B=TZ to confirm the adjustment value TZ, and add the confirmed adjustment value TZ to Dz. If TZ>DJ, add DJ to Dz;

[0027] The pathological data of different chips at the current moment are received based on the determined adjustment sequence. When the subsequently monitored L1+L2<Y1, the original ratio sequence confirmation method is re-executed to receive the pathological data.

[0028] Preferably, it also includes:

[0029] A management database is used to store the received pathological data of different chips, including the relevant data that has been processed with current limiting or has not been processed with current limiting, and the pathological data belonging to different chips are stored in different storage spaces;

[0030] The classification processing end classifies the different pathological data stored in different storage spaces, classifies the different pathological data one by one according to the set classification table, and identifies whether there are missing items in the pathological data during the classification process; the specific method is:

[0031] Based on the set classification table, different pathological data in the same storage space are screened, and pathological data belonging to the same classification are classified into the same classification table. The classification table is a preset table, and each title ID is set in advance. The pathological data to be screened is synchronized with the title ID;

[0032] Identify whether the pathological data of this stage has been received. The pathological data is set with an end mark. When such an end mark is identified, it means that the pathological data has been received. 3 minutes after the pathological data is received, identify whether the relevant classification table is complete. If complete, no processing is performed;

[0033] If it is incomplete, the missing items within the classification table are identified, and the identified missing items are displayed on an external display terminal for external personnel to view.

[0034] The present invention provides an infectious disease processing data management platform containing data from different organ chips. Compared with the prior art, it has the following beneficial effects:

[0035] The present invention performs current limiting processing on chip data generated by different organ chips, and preferentially evaluates whether the chip data generated at different times need to be current limited, and then performs unified current limiting based on the evaluation results and the generation amount at the corresponding time. Subsequently, the reserve change of different chips after the current limiting processing is analyzed, and the relevant ratio of the current limiting is adjusted again based on the specific reserve change value. It can not only effectively perform relevant current limiting on the data, so that the data that needs to be received will not be congested, thereby ensuring the normal reception of the data, but also reasonably digest the reserves of different chips simultaneously to ensure that several chips can be digested and received synchronously;

[0036] For the pathological data of different chips received by this platform, different pathological data are divided into the same storage partition, and then the pathological data in the same storage partition are classified to ensure that different pathological data can be effectively managed. At the same time, it can also identify whether the data is missing during the data classification process and display it in time. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] FIG1 is a schematic diagram of the principle framework of the present invention;

[0038] FIG. 2 is a schematic diagram showing the determination of the current limiting process of the present invention. DETAILED DESCRIPTION

[0039] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0040] Example 1

[0041] Please refer to Figure 1. This application provides an infectious disease processing data management platform containing different organ chip data, including a chip data receiving end, a concurrent receiving and evaluating end, a concurrent current limiting processing end, a reserve monitoring end, a current limiting strategy adjustment end, a management database, and a classification processing end;

[0042] The chip data receiving end is electrically connected to the concurrent receiving and evaluating end input node, and the concurrent receiving and evaluating end is electrically connected to the concurrent current limiting processing end input node, and the concurrent current limiting processing end is electrically connected to the reserve monitoring end, the management database or the current limiting strategy adjustment end input node, respectively, and the management database is bidirectionally connected to the classification processing end;

[0043] Among them, the chip data receiving end receives the pathological data generated by different chips in real time, and transmits the real-time received pathological data to the concurrent receiving and evaluation end. Specifically, when each organ chip generates pathological data, it will continue a disease process, and this disease process will generate relevant pathological data. Each different disease process (experimental process) will generate different pathological data;

[0044] Among them, in conjunction with Figure 2, the concurrent receiving and evaluating end identifies whether the pathological data of different chips received at the current moment will cause a high concurrent processing process. If so, the concurrent current limiting processing end is executed to perform current limiting processing. If not, the pathological data of different chips received at the current moment are transmitted to the management database;

[0045] The specific method of identification is as follows:

[0046] Confirm the preset standard quantity L that this management platform can accept, where L is the preset value, and its specific value is determined by the operator based on experience;

[0047] The pathological data capacity generated by different chips at the current moment is calibrated as R i-k , where i represents different chips and k represents different moments.i-k Perform summation to determine the total capacity value Rz at the current moment;

[0048] If L≥Rz, the pathological data of different chips generated at the current moment are transmitted to the management database. If L<Rz, it means that when this platform receives data, it is easy to have a high-concurrency data receiving and processing process, which may cause the loss of pathological data in serious cases. Therefore, the concurrent current limiting processing end is executed to perform current limiting processing to ensure that there will be no high-concurrency process of the data, so as to ensure that the data can be received normally;

[0049] Example: There are three different chips, namely chip A, chip B and chip C.

[0050] The preset standard amount L is set by the operator as 100MB based on experience;

[0051] At time 1, the pathological data capacity generated by chip A is R 1-1 = 20MB, the pathological data capacity generated by chip B is R 2-1 = 30MB, the pathological data capacity generated by chip C is R 3-1 =15MB.

[0052] Then the total capacity value at the current moment is Rz=R 1-1 +R 2-1 +R 3-1 =20+30+15=65MB.

[0053] Since L (100 MB) ≥ Rz (65 MB), the pathological data of different chips generated at the current moment are transmitted to the management database.

[0054] For example, at time 2, the pathological data capacity generated by chip A is R 1-2 = 40MB, the pathological data capacity generated by chip B is R 2-2 = 50MB, the pathological data capacity generated by chip C is R 3-2 =20MB.

[0055] At this time, the total capacity value Rz=R 1-2 +R 2-2 +R 3-2 =40+50+20=110MB.

[0056] Because L (100MB) < Rz (110MB), this means that when this platform receives data, there is a high concurrency data receiving and processing process, which may cause pathological data loss. Therefore, it is necessary to execute the concurrent current limiting processing end to perform current limiting processing to ensure that the data can be received normally.

[0057] Among them, the concurrent current limiting processing end performs current limiting processing on the pathology capacity generated by different chips based on the different pathology data capacities sent by different chips at the current moment, and caches the limited part of the pathology data, and the cached part of the pathology data is processed again at the next moment. Among them, the specific method of performing current limiting processing is:

[0058] The capacity of different pathological data sent by different chips at the current moment is calibrated as R i-k , several groups R i-k Perform ratio processing and determine the ratio sequence. For example, there are three groups of R i-k , respectively 15, 20 and 25, then the ratio sequence generated after ratio processing is: 15:20:25=3:4:5;

[0059] Divide the preset standard quantity L that this management platform can receive into several different standard processing values ​​CL according to the determined ratio sequence i , its standard treatment value CL i The ratio is the ratio sequence, based on the determined standard processing value CL i And the pathological data capacity R of the corresponding chip i-k , determine the cache volume HC generated by the corresponding chip at this moment i =R i-k -CL i , and the corresponding data capacity is the standard processing value CL i The relevant pathological data is transmitted to the management database;

[0060] When processing the subsequent moments, if the total capacity value Rz confirmed at the corresponding moment is L>Rz, data is randomly extracted from the cached data until L≥Rz, and the platform receives the extracted data and the pathological data capacity generated at this moment;

[0061] Example: The preset standard volume L that this management platform can receive is 100. At the current moment, there are three different chips, and the pathology data capacities sent are:

[0062] Chip A: R 1-k =30;

[0063] Chip B: R 2-k =40;

[0064] Chip C: R 3-k =50;

[0065] First, perform ratio processing, 30:40:50=3:4:5.

[0066] Then the preset standard quantity L is divided into different standard processing values ​​CL according to this ratio sequencei :

[0067] CL1=30(3 / (3+4+5)×100)

[0068] CL2=40(4 / (3+4+5)×100)

[0069] CL3=50(5 / (3+4+5)×100)

[0070] Next, calculate the cache amount:

[0071] The cache capacity of chip A is H1=30-30=0

[0072] The cache capacity of chip B is H2 = 40-40 = 0

[0073] The cache capacity of chip C is H3=50-50=0

[0074] Assume that at some subsequent moment, the total capacity value Rz is 80, because L (100) > Rz (80), at this time, data is randomly extracted from the cache, for example, 20 is extracted from the cache of chip C. Then, the total amount of data received by the platform is 80 + 20 = 100, satisfying L ≥ Rz, and the extraction and reception of data is stopped.

[0075] The reserve monitoring end monitors the cache reserve generated in the continuous processing process in real time, and generates a cache reserve change curve for different chips. Based on the cache reserve change curve generated in real time, it is evaluated whether the original current limiting strategy needs to be adjusted, and an adjustment signal is generated and transmitted to the current limiting strategy adjustment end. The specific method of performing the evaluation is as follows:

[0076] Based on the different total cache amounts generated by different chips (the total cache amount is the total cache amount corresponding to several different moments), the cache amount reserve change curves of different chips are generated in real time, and the cache amount reserve change curves of multiple groups of different chips are located in the same two-dimensional coordinate system, the horizontal coordinate of the two-dimensional coordinate system is the timeline, and the vertical coordinate axis is the cache amount parameter;

[0077] Based on several groups of cache volume change curves generated in real time, the average values ​​of several cache volumes at the same time are determined, and then based on the confirmed average values, the average change curve is determined;

[0078] Process several groups of real-time changing buffer reserve change curves and mean change curves: mark the buffer reserve change curve at the top of the mean change curve as the upper curve, mark the buffer reserve change curve at the bottom of the mean change curve as the lower curve, identify the vertical distance L1 between the upper curve and the mean change curve at the current moment, and then identify the vertical distance L2 between the lower curve and the mean change curve at the current moment;

[0079] If L1+L2≥Y1, where Y1 is a preset value, and its specific value is determined by the operator based on experience, an adjustment signal is generated and transmitted to the current limiting strategy adjustment terminal;

[0080] If L1+L2<Y1, monitoring is performed.

[0081] This type of processing here means that after the current limiting processing, some chips generate more data flow per unit time, which causes the storage generated by the corresponding chip to gradually increase. In response to this type of current limiting situation, it is necessary to adjust the original current limiting method, because the original current limiting method will cause too much storage of a certain type of chip, and it will take a long time to receive and process such data later, so it is necessary to re-adjust the strategy.

[0082] Among them, the current limiting strategy adjustment end, based on the generated adjustment signal, makes relevant adjustments to the ratio sequence confirmed at the current moment and the real-time buffer reserve change curve, and determines the adjustment sequence. Subsequently, the pathological data is limited according to the adjustment sequence. The specific method for determining the adjustment sequence is as follows:

[0083] Based on the determined adjustment signal, determine the chip to which the upper curve or the lower curve belongs, and determine the relevant ratio B, where B=L2÷L1;

[0084] Determine the internal ratio corresponding to the chip to which the upper curve belongs from the confirmed ratio sequence, and mark it as the ratio to be increased Dz, and then determine the internal ratio corresponding to the chip to which the lower curve belongs, and mark it as the ratio to be decreased DJ;

[0085] Use DJ×B=TZ to confirm the adjustment value TZ, and add the confirmed adjustment value TZ to Dz. If TZ>DJ, add DJ to Dz (then the ratio at the original position of DJ changes to 0, and the ratio at the position of Dz changes to: Dz+DJ). The reason why TZ>DJ is that B>1. In this case, L2 is much larger than L1, so there is a large difference in the reserves between the chips, so the data receiving process of the chip belonging to the lower curve in the next stage can be stopped, and the discarded data reception amount is received with the data generated by the chip belonging to the upper curve to reduce the difference between the reserves;

[0086] Based on the determined adjustment sequence, the pathological data of different chips at the current moment are received, and when the subsequently monitored L1+L2<Y1, the original ratio sequence confirmation method is re-executed to receive the pathological data;

[0087] By adopting the current limiting method of adjusting sequence and ratio sequence to receive the pathological data of different chips one by one, it is possible to fully avoid the high-concurrency processing process in the data receiving and processing process, so that the data can be effectively processed.

[0088] Example 2

[0089] In the specific implementation process of this embodiment, compared with the above embodiment, this embodiment mainly focuses on the management process of pathological data received by this platform, and classifies different pathological data into related categories;

[0090] Its specific execution end is the management database and classification processing end;

[0091] The management database stores the received pathological data of different chips, including the relevant data that has been processed with current limiting or not, and stores the pathological data belonging to different chips in different storage spaces;

[0092] The classification processing end classifies the different pathological data stored in different storage spaces, classifies the different pathological data one by one according to the set classification table, and identifies whether there are missing items in the pathological data during the classification process. The specific method of classification is as follows:

[0093] Based on the set classification table, different pathological data in the same storage space are screened, and pathological data belonging to the same classification are classified into the same classification table. The classification table is a preset table, and each title ID is set in advance. The pathological data to be screened is synchronized with the title ID;

[0094] Identify whether the pathological data of this stage has been received. The pathological data is set with an end mark. When such an end mark is identified, it means that the pathological data has been received. 3 minutes after the pathological data is received, identify whether the relevant classification table is complete. If complete, no processing is performed;

[0095] If it is incomplete, the missing items within the classification table are identified, and the identified missing items are displayed on an external display terminal for external personnel to view.

[0096] Example: To build a simple infectious disease pathology database, there may be the following tables:

[0097] "Infectious Disease Table" (Infectious Disease ID, Infectious Disease Name, Pathogen, Symptom Description)

[0098] "Patient Table" (patient ID, name, age, gender)

[0099] "Patient_Infectious Disease Association Table" (association ID, patient ID, infectious disease ID, infection time)

[0100] "Symptom table" (symptom ID, symptom name, symptom description)

[0101] "Infectious Disease_Symptom Association Table" (association ID, infectious disease ID, symptom ID)

[0102] Through such a structural design, different infectious diseases and their related pathological data can be clearly managed, and various query and analysis needs can be supported.

[0103] Some of the data in the above formulas are dimensionless and numerically calculated. Meanwhile, the contents not described in detail in this specification belong to the prior art known to those skilled in the art.

[0104] The above embodiments are only used to illustrate the technical method of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical method of the present invention may be modified or replaced by equivalents without departing from the spirit and scope of the technical method of the present invention.

Claims

1. An infectious disease processing data management platform containing different organ chip data, characterized in that: include: The chip data receiving end receives the pathological data generated by different chips in real time; The concurrent receiving and evaluating end identifies whether the pathological data of different chips received at the current moment will cause a high concurrent processing process. If so, the concurrent current limiting processing end is executed to perform current limiting processing. If not, the pathological data of different chips received at the current moment are transmitted to the management database. The specific method is as follows: Confirm the preset standard quantity L that this management platform can accept, where L is the preset value; The pathological data capacity generated by different chips at the current moment is calibrated as R i-k , where i represents different chips and k represents different moments. i-k Perform summation to determine the total capacity value Rz at the current moment; If L≥Rz, the pathological data of different chips generated at the current moment are transmitted to the management database. If L<Rz, the concurrent current limiting processing end is executed to perform current limiting processing; The concurrent current limiting processing end performs current limiting processing on the pathology capacity generated by different chips based on the different pathology data capacities sent by different chips at the current moment, and caches the limited part of the pathology data. The cached part of the pathology data is processed again at the next moment. The specific method is as follows: The capacity of different pathological data sent by different chips at the current moment is calibrated as R i-k , several groups R i-k Perform ratio processing and determine the ratio sequence; Divide the preset standard quantity L that this management platform can receive into several different standard processing values ​​CL according to the determined ratio sequence i , based on the determined standard treatment value CL i And the pathological data capacity R of the corresponding chip i-k , determine the cache volume HC generated by the corresponding chip at this moment i =R i-k -CL i , and the corresponding data capacity is the standard processing value CL i The relevant pathological data is transmitted to the management database; When processing the subsequent moments, if the total capacity value Rz confirmed at the corresponding moment is L>Rz, data is randomly extracted from the cached data until L≥Rz, and the platform receives the extracted data and the pathological data capacity generated at this moment; The reserve monitoring end monitors the cache reserves generated in the continuous processing process in real time, and generates cache reserve change curves for different chips. Based on the real-time generated cache reserve change curves, it is evaluated whether the original current limiting strategy needs to be adjusted, and an adjustment signal is generated and transmitted to the current limiting strategy adjustment end. The specific method is as follows: Based on the different total cache amounts generated by different chips, cache amount reserve change curves of different chips are generated in real time, and the cache amount reserve change curves of multiple groups of different chips are located in the same two-dimensional coordinate system; Based on several groups of cache volume change curves generated in real time, the average values ​​of several cache volumes at the same time are determined, and then based on the confirmed average values, the average change curve is determined; Process several groups of real-time changing buffer reserve change curves and mean change curves: mark the buffer reserve change curve at the top of the mean change curve as the upper curve, mark the buffer reserve change curve at the bottom of the mean change curve as the lower curve, identify the vertical distance L1 between the upper curve and the mean change curve at the current moment, and then identify the vertical distance L2 between the lower curve and the mean change curve at the current moment; If L1+L2≥Y1, where Y1 is a preset value, an adjustment signal is generated and transmitted to the current limiting strategy adjustment terminal; The flow limiting strategy adjustment end, based on the generated adjustment signal, makes relevant adjustments to the ratio sequence confirmed at the current moment and the real-time buffer reserve change curve, and determines the adjustment sequence. Subsequently, the pathological data is limited according to the adjustment sequence. The specific method is as follows: Based on the determined adjustment signal, determine the chip to which the upper curve or the lower curve belongs, and determine the relevant ratio B, and B=L2÷L1; Determine the internal ratio corresponding to the chip to which the upper curve belongs from the confirmed ratio sequence, and mark it as the ratio to be increased Dz, and then determine the internal ratio corresponding to the chip to which the lower curve belongs, and mark it as the ratio to be decreased DJ; Use DJ×B=TZ to confirm the adjustment value TZ, and add the confirmed adjustment value TZ to Dz. If TZ>DJ, add DJ to Dz; Based on the determined adjustment sequence, the pathological data of different chips at the current moment are received, and when the subsequently monitored L1+L2<Y1, the original ratio sequence confirmation method is re-executed to receive the pathological data; A management database is used to store the received pathological data of different chips, including the relevant data that has been processed with current limiting or has not been processed with current limiting, and the pathological data belonging to different chips are stored in different storage spaces; The classification processing end classifies the different pathological data stored in different storage spaces, classifies the different pathological data one by one according to the set classification table, and identifies whether there are missing items in the pathological data during the classification process.

2. An infectious disease processing data management platform containing different organ chip data according to claim 1, characterized in that: If L1+L2<Y1, monitoring is performed.

3. The infectious disease processing data management platform containing different organ chip data according to claim 1, characterized in that: The specific method of the classification processing end for classifying different pathological data one by one is: Based on the set classification table, different pathological data in the same storage space are screened, and pathological data belonging to the same classification are classified into the same classification table. The classification table is a preset table, and each title ID is set in advance. The pathological data to be screened is synchronized with the title ID; Identify whether the pathological data of this stage has been received. The pathological data is set with an end mark. When such an end mark is identified, it means that the pathological data has been received. 3 minutes after the pathological data is received, identify whether the relevant classification table is complete. If complete, no processing is performed; If it is incomplete, the missing items within the classification table are identified, and the identified missing items are displayed on an external display terminal for external personnel to view.